IGF2BP1 and head and neck cancer: In our in-house cohort, which comprised fresh tumor biopsy specimens obtained from 193 head and neck cancer patients at Fujian Cancer Hospital (from January 2015 to January 2018), a comparison of DEGs between cancer and paraneoplastic tissues revealed a significant upregulation of IGF2BP1 in cancer tissues (Figure 2A).